Joanna B. Goldberg

2 weeks ago | microbiologyresearch.org | Joshua Robertson |Joanna B. Goldberg |Rosmarie Rippka |Josette Deruelles

Article metrics loading... /content/journal/micro/10.1099/mic.0.001553Download as PowerPoint /deliver/fulltext/micro/171/4/mic001553.html?itemId=/content/journal/micro/10.1099/mic.0.001553&mimeType=html&fmt=ahah References Elborn JS. Cystic fibrosis. Lancet 2016; 388:2519–2531 [View Article] [PubMed][Google Scholar] De Boeck K. Cystic fibrosis in the year 2020: a disease with a new face. Acta Paediatr 2020; 109:893–899 [View Article] [PubMed][Google Scholar] Lukasiak A, Zajac M.

Jun 28, 2024 | biorxiv.org | Joshua Robertson |Joanna B. Goldberg |Rachel Done |Samatha Prezioso

AbstractThe opportunistic pathogen Pseudomonas aeruginosa causes debilitating lung infections in people with cystic fibrosis, as well as eye, burn, and wound infections in otherwise immunocompetent individuals. Many of P. aeruginosa's virulence factors are regulated by environmental changes associated with human infection, such as a change in temperature from ambient to human body temperature. One such virulence factor is protease IV (PIV).

May 30, 2023 | biorxiv.org | Cristian V. Crisan |Daria Van Tyne |Joanna B. Goldberg

New Results doi: https://doi.org/10.1101/2023.05.30.542968 AbstractAntagonistic behaviors between bacterial cells can have profound effects on microbial populations and disease outcomes. Polymicrobial interactions may be mediated by contact-dependent proteins with antibacterial properties. The Type VI Secretion System (T6SS) is a macromolecular weapon used by Gram-negative bacteria to translocate proteins into adjacent cells.